Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins

Details for Australian Patent Application No. 2005238308 (hide)

Owner GlycoFi, Inc.

Inventors Bobrowicz, Piotr

Agent Spruson & Ferguson

Pub. Number AU-B-2005238308

PCT Pub. Number WO2005/106010

Priority 60/620,186 18.10.04 US; 60/566,736 29.04.04 US

Filing date 29 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 14 May 2009

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/80 (2006.01) Mutation or genetic engineering - for fungi

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

C12P 21/00 (2006.01) Preparation of peptides or proteins

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/106010 Priority application(s): WO2005/106010

14 May 2009 Application Accepted

  Published as AU-B-2005238308

10 September 2009 Standard Patent Sealed

8 October 2009 Corrigenda

  Applications Accepted - Name Index Under the name GlycoFi, Inc., Application No. 2005238308, under INID (30) delete all reference to 60/566,736

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238313-Process for the preparation of telithromycin

2005238300-Compositions and methods for treating proliferative disorders such as NK-type LDGL